Skip to content

Irbesartan

Avapro, Aprovel, Irbesartan Winthrop, Irbesartan Zentiva, Karvea (irbesartan) is a small molecule pharmaceutical. Irbesartan was first approved as Avapro on 1997-08-26. It is used to treat diabetic nephropathies, hypertension, and left ventricular dysfunction in the USA. It has been approved in Europe to treat hypertension. It is known to target sodium/bile acid cotransporter and type-1 angiotensin II receptor.
Trade Name Aprovel, Irbesartan Winthrop, Irbesartan Zentiva, Karvea
Common Name Irbesartan
Indication diabetic nephropathies, hypertension, left ventricular dysfunction
Drug Class Angiotensin II receptor antagonists
Irbesartan
Get full access now